Tandem Diabetes Care, Inc. (TNDM)

22.45 -0.15 (-0.66%) USD  |  NASDAQ  |  Dec 17, 15:56
More

Tandem Diabetes Care Research and Development Expense (Annual): 184.17M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for TNDM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Insulet Corp. 219.60M
Abbott Laboratories 2.823B
Integra LifeSciences Holdings Corp. 54.43M
Intuitive Surgical, Inc. 1.145B
iRhythm Technologies, Inc. 71.46M